Former President US Pharmaceutical Business · Bausch Health Companies Inc. (BHC)

Robert Spurr

A named executive officer of Bausch Health Companies in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$4,303,097

Salary $336,538Stock awards $861,105

FY2021: $3,868,624

6th of 7 named executive officers at Bausch Health Companies by FY2022 total.

7 named officers on file for Bausch Health Companies, FY2022

Robert Spurr’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 8 equity grants, each cited to its filing
  • BHC’s disclosed peer group of 13 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Bausch Health Companies’s whole pay program stands against its peers

  • Bausch Health Companies’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BHC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 6, 2023 (DEF 14A).

Free

Get Robert Spurr’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Robert Spurr compensation by year

Bausch Health Companies Summary Compensation Table · all 2 fiscal years held
In US dollars, as Bausch Health Companies reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$636,154$336,538
Bonus$0$0
Stock awards$1,768,210$861,105
Option awards$625,010$874,563
Non-equity incentive$821,200$0
Pension and deferred compensation$0$0
All other$18,050$2,230,891
Total$3,868,624$4,303,097

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bausch Health Companies Inc. DEF 14A filed April 6, 2023, accession 0001140361-23-017057, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Bausch Health Companies Inc. filed document, accession 0001140361-23-017057. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2023.

$3.9M
$4.3M
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU16,476$454,902—
RSU12,358$341,204—
RSU11,534$318,454—
RSU9,223$254,647—
RSU9,026$249,208—
RSU9,004$248,600—
PSU6,392$176,483—
RSU5,642$155,776—
PSU5,492$151,634—
RSU4,567$126,095—
PSU4,502$124,300—
RSU3,378$93,267—

Per the Outstanding Equity Awards at Fiscal Year-End table in Bausch Health Companies Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 18 award rows shown.

Bausch Health Companies’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Joseph PapaFormer Chief Executive Officer$19,781,761
Thomas AppioChief Executive Officer$13,171,461
Tom VadakethExecutive Vice President and Chief Financial Officer$9,011,699
Sam EldessoukyFormer Executive Vice President and Chief Financial Officer$6,152,073
Christina AckermannFormer Executive Vice President and General Counsel and Head of Commercial Operations$4,735,526
Robert Spurr · this pageFormer President US Pharmaceutical Business$4,303,097
Seana CarsonExecutive Vice President and General Counsel$4,212,695

The full Bausch Health Companies compensation record

free company brief

This page is one person within Bausch Health Companies's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Bausch Health Companies proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bausch Health Companies's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Robert Spurr's compensation dossier · One-time report. No refunds.